Ventas Inc (VTR) Stock Price, Quote & News

Company Profile

Ventas, Inc. (NYSE: VTR) is a leading S&P 500 real estate investment trust enabling exceptional environments that benefit a large and growing aging population. With approximately 1,400 properties in North America and the United Kingdom, Ventas occupies an essential role in the longevity economy. The Company's growth is fueled by its approximately 850 senior housing communities, which provide valuable services to residents and enable them to thrive in supported environments. Ventas aims to delive...

Industry: REIT - Healthcare Facilities

Sector: Real Estate

Phone: 877 483 6827

Website: www.ventasreit.com

Address:

300 North LaSalle Street, Suite 1600, Chicago, United States

ZacksResearch Jul. 31 at 6:11 PM

$VTR beats Q2 FFO and revenue — same-store cash NOI on the rise 🏢📈 Year-over-year revenue growth and broad-based segment strength drove the upside. Full Q2 recap here 👉 https://www.zacks.com/stock/news/2644914/ventas-q2-ffo-and-revenues-top-estimates-same-store-cash-noi-rises?cid=sm-stocktwits-2-2644914-teaser-5250&ADID=SYND_STOCKTWITS_TWEET_2_2644914_TEASER_5250

0 · Reply

ZacksResearch Jul. 31 at 4:39 PM

$VTR beats Q2 expectations and raises guidance! 📈 With a 9% jump in FFO per share and revenue soaring 18.3% from the prior-year quarter, Ventas is capitalizing on a multiyear growth opportunity in senior housing. The company also raised its 2025 normalized FFO guidance, signaling confidence in continued performance. Discover the full story behind VTR's growth here 👉 https://www.zacks.com/stock/news/2644914/ventas-q2-ffo-and-revenues-top-estimates-same-store-cash-noi-rises?cid=sm-stocktwits-2-2644914-body-5158&ADID=SYND_STOCKTWITS_TWEET_2_2644914_BODY_5158

0 · Reply

DonCorleone77 Jul. 30 at 8:57 PM

$VTR Ventas reports Q2 normalized FFO 87c, consensus 85c -- Q2 revenue $1.42B, consensus $1.37B. -- Ventas narrows FY25 normalized FFO view to $3.41-$3.46 from $3.36-$3.46, consensus $3.45

0 · Reply

ZacksResearch Jul. 25 at 5:16 PM

$VTR earnings preview — solid SHOP trends, but are rates the drag? Ventas may get a boost from strong operating trends and tenant diversity, though high interest costs could pressure the bottom line. Full outlook here 👉 https://www.zacks.com/stock/news/2617834/whats-in-the-offing-for-ventas-stock-this-earnings-season?cid=sm-stocktwits-2-2617834-teaser-4026&ADID=SYND_STOCKTWITS_TWEET_2_2617834_TEASER_4026

0 · Reply

ZacksResearch Jul. 25 at 3:08 PM

$VTR's Q2 report: Can it maintain its performance? 🏆 Ventas is set to showcase YoY growth in revenue and FFO per share, with senior housing benefiting from an aging population and healthcare spend. However, high interest expenses could weigh in. The Zacks Consensus Estimate projects a 6.3% FFO increase YoY, but unchanged over 2 months. In-depth analysis here 👉 https://www.zacks.com/stock/news/2617834/whats-in-the-offing-for-ventas-stock-this-earnings-season?cid=sm-stocktwits-2-2617834-body-3935&ADID=SYND_STOCKTWITS_TWEET_2_2617834_BODY_3935

0 · Reply

Laynester Jul. 22 at 8:28 PM

$CIFR $VTR $SG $FLNC $CLF That [VTR] Aug Call Option looks good to go!! See all above and in the attached image below for a ATH team PLAYER investment that will fit any price range in your portfolio. Look at any of these tried and proven investments and "pull the trigger" then "set a stop". And at the closing Bell ....[DING] [DING] [DING] +41% 1yr. Elvis just left the bldg.

0 · Reply

PhaseFlow Jul. 16 at 1:58 AM

$VTR $60-64 looks like a good buy zone for a ride to $70+ over the coming months

0 · Reply

OptionRunners Jul. 14 at 5:36 PM

$VTR calls are ITM now trading $2.20

0 · Reply

ZacksResearch Jul. 14 at 4:46 PM

$VTR up 11.6% in 6 months — can it keep climbing? Tailwinds from an aging population, rising healthcare costs, and strong outpatient trends are fueling momentum, along with accretive research portfolio plays. See what could power the next leg higher 👉 https://www.zacks.com/stock/news/2580237/ventas-stock-gains-116-in-6-months-will-the-trend-last?cid=sm-stocktwits-2-2580237-teaser-1652&ADID=SYND_STOCKTWITS_TWEET_2_2580237_TEASER_1652

0 · Reply

ZacksResearch Jul. 14 at 3:09 PM

Is Ventas ($VTR) set for a multiyear growth run? 🚀 With a 11.6% gain in six months, this Zacks Rank #3 REIT is well-poised to benefit from the aging population trend, with SHOP same-store cash NOI expected to grow 11-16% by 2025. Outpatient medical visits are also on the rise, benefiting the OM&R portfolio. Find out if VTR's momentum will continue here 👉 https://www.zacks.com/stock/news/2580237/ventas-stock-gains-116-in-6-months-will-the-trend-last?cid=sm-stocktwits-2-2580237-body-1603&ADID=SYND_STOCKTWITS_TWEET_2_2580237_BODY_1603

0 · Reply

Ventas, Inc. (VTR) Q2 2025 Earnings Call Transcript

Jul 30, 2025, 6:09 PM EDT - 3 days ago

Healthcare REIT Ventas raises annual FFO forecast on steady demand for senior housing

Jul 30, 2025, 4:10 PM EDT - 3 days ago

Ventas Reports 2025 Second Quarter Results

Jul 14, 2025, 2:06 AM EDT - 19 days ago

Ventas Looks Bullish

Jul 8, 2025, 8:12 AM EDT - 25 days ago

The Best Growth Stocks to Buy

ALGM AMZN AVGO BURL CTRE DAR DXCM

Jul 7, 2025, 4:20 PM EDT - 26 days ago

Ventas Announces Second Quarter 2025 Earnings Release Date and Conference Call

Jun 23, 2025, 1:24 PM EDT - 5 weeks ago

JPMorgan's REIT Reshuffle: Ventas Stock Climbs, Cold Storage Giants Slip

Jun 22, 2025, 12:45 PM EDT - 5 weeks ago

Ventas: Guidance Increased As Occupancy Continues To Improve

Jun 6, 2025, 1:33 PM EDT - 2 months ago

Final Trades: Amazon, Jefferies Financial, E.L.F. Beauty and Ventas

AMZN ELF JEF

Jun 3, 2025, 7:33 PM EDT - 2 months ago

Ventas, Inc. (VTR) CEO Debra A. Cafaro Hosts Nareit REITweek: 2025 Investor Conference (Transcript)

May 29, 2025, 5:31 PM EDT - 2 months ago

Ventas Announces Pricing of Senior Notes Offering

May 29, 2025, 7:02 AM EDT - 2 months ago

U.S. REIT Same-Store Net Operating Income Growth Slips In Q1

AHR CDP CMCT COLD DHC DOC FR

May 28, 2025, 8:30 AM EDT - 2 months ago

Ventas Issues Business Update and Will Present at Nareit's REITweek 2025 Investor Conference

May 13, 2025, 5:07 PM EDT - 2 months ago

Ventas Declares Quarterly Dividend of $0.48 Per Common Share

May 1, 2025, 4:07 PM EDT - 3 months ago

Ventas, Inc. (VTR) Q1 2025 Earnings Call Transcript

Apr 30, 2025, 5:56 PM EDT - 3 months ago

Healthcare REIT Ventas beats quarterly FFO estimates on stable senior housing demand

Apr 30, 2025, 4:10 PM EDT - 3 months ago

Ventas Reports 2025 First Quarter Results

Apr 21, 2025, 12:22 PM EDT - 3 months ago

The State Of REITs: April 2025 Edition

AHH AMT BBRE CCI CLDT CTRE DFAR

Apr 8, 2025, 1:00 PM EDT - 4 months ago

The Big 3: TJX, VTR, ORCL

ORCL TJX

Apr 8, 2025, 7:15 AM EDT - 4 months ago

Why Ventas Is Poised For Strong Long-Term Returns

Apr 4, 2025, 4:18 PM EDT - 4 months ago

Ventas Announces First Quarter 2025 Earnings Release Date and Conference Call

Apr 3, 2025, 10:22 AM EDT - 4 months ago

Cramer's Stop Trading: Ventas

Mar 4, 2025, 11:57 PM EST - 5 months ago

Demographic Trends Shaping REIT Portfolio Construction

AHR AVB CBRE CVX HIW IVT ORCL

Mar 4, 2025, 5:22 PM EST - 5 months ago

Ventas, Inc. (VTR) Presents at Citi 2025 Global Property CEO Conference (Transcript)

Feb 28, 2025, 4:39 PM EST - 5 months ago

Ventas to Participate in Investor Meetings at Citi 2025 Global Property CEO Conference

Feb 13, 2025, 1:12 PM EST - 6 months ago

Ventas, Inc. (VTR) Q4 2024 Earnings Call Transcript

Feb 12, 2025, 5:27 PM EST - 6 months ago

Healthcare REIT Ventas beats quarterly FFO estimates on senior housing demand

Feb 12, 2025, 4:10 PM EST - 6 months ago

Ventas Reports 2024 Full Year Results, Provides 2025 Outlook and Increases Dividend

Feb 1, 2025, 8:30 AM EST - 6 months ago

Don't Miss This REIT Opportunity: The Silver Tsunami

AHR SILA VNQ WELL

Jan 27, 2025, 8:00 AM EST - 6 months ago

Ventas: Strong Outlook With Double-Digit SHOP NOI Growth

Jan 25, 2025, 6:55 AM EST - 6 months ago

How The 'Smart Money' Is Investing In REITs Right Now

CCI CPT DLR EQIX EQR FR HR

Jan 23, 2025, 6:55 AM EST - 6 months ago

My Biggest Losses Of 2024

AVB EPRT GMRE GNL ILPT IRS OUT

Jan 21, 2025, 5:38 PM EST - 6 months ago

Ventas Announces Tax Treatment Of 2024 Distributions

Jan 16, 2025, 4:30 PM EST - 7 months ago

Ventas Announces Fourth Quarter 2024 Earnings Release Date and Conference Call

Jan 15, 2025, 7:04 AM EST - 7 months ago

These 4%+ Yielding ‘Bond Proxies' Are Top Picks For Trump 2.0

Dec 19, 2024, 6:52 AM EST - 8 months ago

Ventas Reaches Mutually Beneficial Agreements with Brookdale Senior Living

Dec 10, 2024, 4:53 PM EST - 8 months ago

Ventas Declares Fourth Quarter 2024 Dividend of $0.45 Per Common Share

Dec 3, 2024, 9:16 AM EST - 8 months ago

Ventas Comments on Master Lease with Brookdale Senior Living

Nov 20, 2024, 4:30 PM EST - 9 months ago

Ventas Earns Nareit 2024 Healthcare “Leader in the Light” Award

Nov 15, 2024, 4:14 PM EST - 9 months ago

Ventas to Participate in Investor Meetings at Nareit's REITworld 2024 Annual Conference

Nov 14, 2024, 8:30 AM EST - 9 months ago

Ventas Announces Pricing of an Underwritten Offering of 10.6 Million Shares of Common Stock

Nov 13, 2024, 4:47 PM EST - 9 months ago

Ventas Announces Underwritten Offering of 10.6 Million Shares of Common Stock

Nov 10, 2024, 11:40 AM EST - 9 months ago

Ventas: Growth Set To Continue In The Years Ahead

Nov 2, 2024, 12:20 AM EDT - 9 months ago

MOBs, Office But No Need For Life Support

AHR CHCT DHC DOC GMRE HR SILA

Oct 31, 2024, 4:55 PM EDT - 9 months ago

Ventas, Inc. (VTR) Q3 2024 Earnings Call Transcript

Oct 30, 2024, 5:43 PM EDT - 9 months ago

Healthcare REIT Ventas raises annual FFO per share forecast

Oct 30, 2024, 4:11 PM EDT - 9 months ago

Ventas Reports 2024 Third Quarter Results

Oct 27, 2024, 9:39 AM EDT - 9 months ago

These REITs Trade At Discounts, But Should They?

ABNB AHH CTO HST KIM NLOP WELL

Oct 4, 2024, 4:14 PM EDT - 10 months ago

Ventas Announces Third Quarter 2024 Earnings Release Date and Conference Call

Sep 17, 2024, 4:39 PM EDT - 11 months ago

Ventas Declares Third Quarter 2024 Dividend of $0.45 Per Common Share

ZacksResearch Jul. 31 at 6:11 PM

0 · Reply

ZacksResearch Jul. 31 at 4:39 PM

0 · Reply

DonCorleone77 Jul. 30 at 8:57 PM

$VTR Ventas reports Q2 normalized FFO 87c, consensus 85c -- Q2 revenue $1.42B, consensus $1.37B. -- Ventas narrows FY25 normalized FFO view to $3.41-$3.46 from $3.36-$3.46, consensus $3.45

0 · Reply

ZacksResearch Jul. 25 at 5:16 PM

0 · Reply

ZacksResearch Jul. 25 at 3:08 PM

0 · Reply

Laynester Jul. 22 at 8:28 PM

0 · Reply

PhaseFlow Jul. 16 at 1:58 AM

$VTR $60-64 looks like a good buy zone for a ride to $70+ over the coming months

0 · Reply

OptionRunners Jul. 14 at 5:36 PM

$VTR calls are ITM now trading $2.20

0 · Reply

ZacksResearch Jul. 14 at 4:46 PM

0 · Reply

ZacksResearch Jul. 14 at 3:09 PM

0 · Reply

Laynester Jul. 12 at 1:19 PM

$VTR 8/15/2025 CALL OPTION(s) - Strike $67.50 - P/L + 60%

0 · Reply

OptionRunners Jul. 11 at 3:06 PM

$VTR Buyer of the August 15th $65 calls 800 times for $1.35-$1.50

0 · Reply

NVDAMillionaire Jul. 8 at 3:06 PM

$VTR Outstanding article that hits the mark on VTR's current state. So if you want to refresh your VTR insights or learn about VTR from scratch, this is a must read. https://beyondspx.com/article/ventas-riding-the-demographic-wave-with-operational-edge-and-strategic-investments-nyse-vtr

0 · Reply

Ath4c Jul. 7 at 3:01 AM

$VTR

0 · Reply

RunnerSignals Jun. 23 at 7:57 PM

Fresh Upgrades Rolling In for $AMD $EL $ABM $FDX $VTR just got bullish nods from Wall Street https://stocksrunner.com/news/2025-06-23-wall-street-analysts-boost-confidence-in-these-stocks-with-fresh-upgrades-and-bullish-targets

0 · Reply

JarvisFlow Jun. 23 at 1:57 PM

Scotiabank has adjusted their stance on Ventas ( $VTR ), setting the rating to Sector Perform with a target price of 71 → 72.

0 · Reply

JarvisFlow Jun. 23 at 11:30 AM

JP Morgan has updated their rating for Ventas ( $VTR ) to Overweight with a price target of 72.

0 · Reply

ZacksResearch May. 29 at 5:51 PM

$VTR provides a business update that highlights delivering profitable growth in senior housing. It also increased the 2025 normalized FFO per share guidance. Read the full story here: https://www.zacks.com/stock/news/2479185/ventas-issues-business-update-raises-2025-normalized-ffo-guidance?cid=sm-stocktwits-2-2479185-teaser&ADID=SYND_STOCKTWITS_TWEET_2_2479185_TEASER

0 · Reply

ZacksResearch May. 29 at 4:03 PM

$VTR raises 2025 FFO guidance — why it’s bullish for Ventas! 🚀 Healthy fundamentals in senior housing and a projected 7% YoY growth in FFO per share at the midpoint of the guidance range are key drivers. The SHOP segment is poised to benefit from an aging population and increased healthcare spending. 📈 See why Ventas is positioned for growth 👉 https://www.zacks.com/commentary/2479185/ventas-issues-business-update-raises-2025-normalized-ffo-guidance?cid=sm-stocktwits-2-2479185-body&ADID=SYND_STOCKTWITS_TWEET_2_2479185_BODY

0 · Reply

JasonCO May. 13 at 8:30 PM

$VTR entering area of interest soon

0 · Reply

macroaxis May. 10 at 7:39 PM

$VTR - Risk alert: Ventas max pain price is slumping https://www.macroaxis.com/stock-options/VTR/Ventas-Inc?utm_source=dlvr.it&utm_medium=stocktwits

0 · Reply

JarvisFlow May. 7 at 5:45 PM

RBC Capital updates rating for Ventas ( $VTR ) to Outperform, target set at 74 → 75.

0 · Reply

Market Cap	30.32B
Revenue (ttm)	4.92B
Net Income (ttm)	81.15M
EPS (ttm)	N/A
PE Ratio	20.02
Forward PE	19.26
Profit Margin	1.65%
Debt to Equity Ratio	1.10

Volume	2,813,800
Avg Vol	3,207,024
Day's Range	N/A - N/A
Shares Out	451.30M
Stochastic %K	71%
Beta	0.87
Analysts	Strong Sell
Price Target	$75.39